Comparison results
| Results: Differences General | ✘N47 | ✘H48 | |||||||||||||
| Related research | Analogs | Analogs | |||||||||||||
| |||||||||||||||
| Distinctive symptoms | |||||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | |||||||||||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | |||||||||||||
| phimosis in children | 68% | — | |||||||||||||
| optic neuritis | — | 57% | |||||||||||||
| urine is released drop by drop | 55% | — | |||||||||||||
| neuritis | — | 57% | |||||||||||||
| inflammation of the foreskin | 53% | — | |||||||||||||
| neuralgia | — | 56% | |||||||||||||
| paraphimosis | 53% | — | |||||||||||||
| neurological disorders | — | 46% | |||||||||||||
| genital pain in men | 48% | — | |||||||||||||
| not classified in other categories | — | 44% | |||||||||||||
| balanoposthitis in boys | 48% | — | |||||||||||||
| scotoma | — | 36% | |||||||||||||
| pain in the penis | 48% | — | |||||||||||||
| narrowing of the fields of vision | — | 34% | |||||||||||||
| penis size | 48% | — | |||||||||||||
| loss of visual fields | — | 34% | |||||||||||||
| crystalluria | 47% | — | |||||||||||||
| multiple sclerosis | — | 32% | |||||||||||||
| discomfort when urinating | 43% | — | |||||||||||||
| consequences of a viral infection | — | 31% | |||||||||||||
| erection painful | 40% | — | |||||||||||||
| adaptation disorders | — | 30% | |||||||||||||
| the skin is very sensitive | 40% | — | |||||||||||||
| lowered | — | 28% | |||||||||||||
| painful urination | 33% | — | |||||||||||||
| inflammation of the eyes | — | 28% | |||||||||||||
| effects of puberty | 32% | — | |||||||||||||
| illness from stress | — | 27% | |||||||||||||
| traumatic illness | 30% | — | |||||||||||||
| weakening of immunity | — | 27% | |||||||||||||
| scarring | 28% | — | |||||||||||||
| clear boundaries | — | 27% | |||||||||||||
| anesthesia | 27% | — | |||||||||||||
| leukoencephalitis | — | 26% | |||||||||||||
| consequences of surgery | 25% | — | |||||||||||||
| serious condition | — | 26% | |||||||||||||
| skin problems | 24% | — | |||||||||||||
| aggressive | — | 25% | |||||||||||||
| pain at the end of urination | 22% | — | |||||||||||||
| visual impairment | — | 25% | |||||||||||||
| history of surgery | 39% | 20% | |||||||||||||
| zpr fatigue from the disease | — | 25% | |||||||||||||
| stress | — | 24% | |||||||||||||
| immunodeficiency | — | 24% | |||||||||||||
| drug disease | — | 22% | |||||||||||||
| damage to the nervous system | — | 22% | |||||||||||||
| onset of illness | — | 22% | |||||||||||||
| patient's condition | — | 20% | |||||||||||||
| inflammation | 24% | 41% | |||||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
